Frailty and Conventional Risk Scores in Patients Undergoing TAVR
The usage of combined risk models of frailty and conventional risk scores significantly enhances prediction of one-year mortality in patients undergoing TAVR, according to a recent publication in the Journal of American…
Intervention in Barbershops Improved Blood Pressure Control
The results of a cluster-randomized trial conducted in black barbershops have been published in the New England Journal of Medicine and were presented by Dr Ronald G. Victor from Los…
Should Patients with Acute Chest Pain Undergo Noninvasive Testing After the Clinical Diagnosis is Made?
The use of noninvasive cardiac tests such as coronary computed tomographic angiography (CCTA) or stress testing for patients presenting to the emergency department with chest pain is not associated with…
Is Sodium Bicarbonate or N-Acetyl-Cysteine Effective in Preventing Contrast-Induced Nephropathy?
In a recent study published in the New England Journal of Medicine, it was found that amongst patients undergoing angiography, sodium bicarbonate is not better than sodium chloride and neither…
CABG Versus PCI in Multivessel Disease
In a recent study published in The Lancet, it was found that there is a mortality benefit for patients with multivessel disease undergoing CABG compared to PCI. However, the reduction…
POISE: 1-Year Outcomes of Perioperative Beta-blockade in Noncardiac Surgery
Dr. Devereaux and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.
TRIUMPH: Low-dose Triple-Combination BP Lowering Pill for Initial Treatment of Hypertension
Dr. Webster and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
Cavitation Phenomenon Damages the Endothelium and Starts the Atherosclerotic Process
Dr. Nguyen and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.
Blood Pressure Reduction in Black Barbershops
Dr. Blyler and Dr. Daaboul Discuss Subscribe on iTunes or Google Play.
PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndrome
Dr. Ardissino and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
MOMENTUM III: HeartMate III demonstrated 2-year Survival Benefit Compared to HeartMate II
Dr. Mehra and Dr. Gibson Discuss Subscribe on iTunes or Google Play.
CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients
Dr. Everett and Dr. Gibson Discuss Subscribe on iTunes or Google Play.